Latest Breaking News On - Chief executive officer john leonard - Page 5 : comparemela.com

CRISPR infusion helps stop swelling caused by genetic disease - study

CRISPR infusion helps stop swelling caused by genetic disease - study
jpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jpost.com Daily Mail and Mail on Sunday newspapers.

New zealandHilary longhurstJohn leonardAmerican college of allergyUniversity of aucklandHealth sciencesIntellia therapeuticsNational human genome research instituteAmerican collegeAnnual scientific meetingIntellia presidentChief executive officer john leonard

Intellia Therapeutics Announces Positive Interim Clinical Data for its Second Systemically Delivered Investigational CRISPR Candidate, NTLA-2002 for the Treatment of Hereditary Angioedema (HAE)

Intellia Therapeutics Announces Positive Interim Clinical Data for its Second Systemically Delivered Investigational CRISPR Candidate, NTLA-2002 for the Treatment of Hereditary Angioedema (HAE)
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

New zealandUnited kingdomUnited statesIan karpAlina liRebecca spaldingHilary longhurstJohn leonardAmerican college of allergyIntellia therapeutics incExchange commissionCorporate communicationsClinical programUniversity of aucklandHealth sciencesIntellia therapeutics

Regeneron (REGN) and Intellia (NTLA) Report Initial Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001

Regeneron (REGN) and Intellia (NTLA) Report Initial Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Alexandra bowieLina liseniorGeorged yancopoulosVesna tosicJohn leonardRegeneron pharmaceuticals incYork heart associationRegeneron genetics centerIntellia therapeutics incTeva pharmaceutical industries ltdExchange commissionCorporate communicationsRegeneron pharmaceuticalsNew york heart associationIntellia presidentChief executive officer john leonard

Intellia and Regeneron Announce Initial Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001, an Investigational CRISPR Therapy for the Treatment of Transthyretin (ATTR) Amyloidosis

Intellia and Regeneron Announce Initial Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001, an Investigational CRISPR Therapy for the Treatment of Transthyretin (ATTR) Amyloidosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomAlexandra bowieLina liseniorGeorged yancopoulosVesna tosicJohn leonardRegeneron pharmaceuticals incYork heart associationRegeneron genetics centerPrnewswire intellia therapeutics incIntellia therapeutics incTeva pharmaceutical industries ltdExchange commissionCorporate communicationsRegeneron pharmaceuticalsNew york heart association

Intellia Therapeutics Receives U S FDA Orphan Drug Designation for NTLA-2002, an Investigational CRISPR Therapy for the Treatment of Hereditary Angioedema

Intellia Therapeutics Receives U S FDA Orphan Drug Designation for NTLA-2002, an Investigational CRISPR Therapy for the Treatment of Hereditary Angioedema
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomLina liseniorJohn leonardDrug designation programDrug administrationIntellia therapeutics incExchange commissionCorporate communicationsClinical programIntellia presidentChief executive officer john leonardNobel prize winningHereditary angioedemahereditaryIntellia therapeuticsintellia therapeuticsLooking statements this